Loading clinical trials...
Loading clinical trials...
Evaluation of Ophthalmic Oxymetazoline as an Adjunct Treatment for Acquired Blepharoptosis Due to Periocular Synkinesis.
Conditions
Interventions
Oxymetazoline 0.1% (Pf) Oph Soln Ud
Preservative free lubricating drops
Locations
1
United States
M.S. Hershey Medical Center
Hershey, Pennsylvania, United States
Start Date
January 11, 2024
Primary Completion Date
January 8, 2026
Completion Date
January 8, 2026
Last Updated
March 9, 2026
NCT03812016
NCT06683651
NCT05715346
NCT06292182
NCT04816175
NCT01848041
Lead Sponsor
Milton S. Hershey Medical Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions